22157.jpg
Global Cancer Diagnostics Market Report 2021-2026: Growth in the Number of Private Diagnostic Centers & Availability of Reimbursement
31 mai 2021 04h43 HE | Research and Markets
Dublin, May 31, 2021 (GLOBE NEWSWIRE) -- The "Cancer Diagnostics Market by Product (Consumables (Anitibodies, Probes), Instruments (Pathology Instruments, Imaging Instruments, Biopsy), Technology...
Inspirata and Fujifilm UK Partnership Generates NHS Success with One Dorset Pathology Network Digital Pathology Engagement
19 mai 2021 04h00 HE | Inspirata, Inc.
London, United Kingdom, May 19, 2021 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology provider Inspirata announced today that University Hospitals Dorset NHS Foundation Trust will...
Inotiv_Logo_CMYK.png
Inotiv, Inc. Announces Debt Financing and Completion of Acquisitions of HistoTox Labs, Inc. and Bolder BioPATH, Inc.
30 avr. 2021 15h40 HE | Inotiv, Inc.
WEST LAFAYETTE, Ind., April 30, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
PRPO logo.png
Current Signed Customers Expected to Generate $1M Annualized Reported Revenues from Precipio’s HemeScreen POL Offering by Q4-2021
26 avr. 2021 11h00 HE | Precipio, Inc.
NEW HAVEN, Conn., April 26, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that currently, the contracted annualized revenues from signed customers...
Inotiv_Logo_CMYK.png
Inotiv, Inc. Announces Plan to Expand the Company’s Internal Operations
19 avr. 2021 07h00 HE | Inotiv, Inc.
WEST LAFAYETTE, Ind., April 19, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv_Logo_CMYK.png
Inotiv, Inc. Announces Expansion of Pharmacology and Pathology Offerings with Agreement to Purchase Bolder BioPATH, Inc.
16 avr. 2021 08h33 HE | Inotiv, Inc.
WEST LAFAYETTE, Ind., April 16, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading provider of non-clinical and analytical contract research...
Inotiv_Logo_CMYK.png
Inotiv, Inc. Enhances Histopathology Offering with Announcement of Agreement to Purchase HistoTox Labs, Inc.
13 avr. 2021 16h35 HE | Inotiv, Inc.
WEST LAFAYETTE, Ind., April 13, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading provider of nonclinical and analytical contract research...
Inspirata Renews Dig
Inspirata Renews Digital Pathology Partnership with The Ohio State University
23 mars 2021 08h00 HE | Inspirata, Inc.
Columbus, Ohio / Tampa, Florida, March 23, 2021 (GLOBE NEWSWIRE) -- Inspirata announced today a multi-year extension of its relationship with The Ohio State University Comprehensive Cancer Center –...
PRPO logo.png
Mr. Ron Andrews joins Precipio’s Board of Directors
03 mars 2021 13h00 HE | Precipio, Inc.
NEW HAVEN, Conn., March 03, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that Mr. Ron Andrews has joined the company’s Board of Directors. As...
PRPO logo.png
Mr. Richard Sandberg is appointed Chairman of Precipio’s Board of Directors
03 mars 2021 11h00 HE | Precipio, Inc.
NEW HAVEN, Conn., March 03, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces the appointment of Mr. Richard Sandberg as Chairman of the Board of...